CLINICAL_TRIALS
trial_result
· 2021-03-10
Clinical Trial Update: A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 2]
Summary
Phase 2a trial of RSLV-132 in systemic lupus erythematosus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Resolve Therapeutics | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2021-03-10